Discussions with USPLeaders of the Advocacy Council and the College had a call with USP officials on Wednesday morning. We had requested it because...
Update on USP 797 and FDA activities related to compounding of patient-specific allergen vials for immunotherapy
The latest from the roundtable on the potential impact of proposed changes to USP 797.